Indoco Remedies Limited — Board Meeting, 22-05-2025: Outcome of Board Meeting

Indoco Remedies has announced a board meeting on the financial results for the quarter and half-year. Revenue slipped to ₹1,649 Cr from ₹1,788 Cr last year, with EBITDA margin narrowing sharply to 8.6% (₹128 Cr vs ₹258 Cr). The company reported a loss of ₹8.7 Cr compared to a profit of ₹117 Cr in the previous period. The board proposed a dividend of ₹0.20 per share (face value ₹2). Management remains hopeful for a turnaround, focusing on its integrated pharma portfolio, strengthened by global regulatory approvals and ongoing R&D investments.